CYCELRION THERAPEUTICS, INC.

301 Binney Street

Cambridge, MA 02142

 

July 30, 2020

 

By EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jason Drory

 

	Re:	Cyclerion Therapeutics, Inc. (the “Company”)
		Registration Statement on Form S-3
		File No. 333-240095

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests acceleration of the effective date of the above referenced Registration Statement to 4:00 p.m., Eastern time, on July 31, 2020, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Hughes Hubbard & Reed LLP, request by telephone that such Registration Statement be declared effective.

 

Please contact Gary J. Simon, of Hughes Hubbard & Reed LLP, special counsel to the Company, at (212) 837-6770, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

 

	Very truly yours,
	CYCLERION THERAPEUTICS, INC.
	By:	/s/ William Huyett
		Name: William Huyett
		Title: Chief Financial Officer
cc:Hughes Hubbard & Reed LLP